Literature DB >> 12455285

[Splenic hematoma after extracorporeal lithotripsy: apropos of a case].

Consuelo Conde Redondo1, Javier Estebanez Zarranz, José Amón Sesmero, Manolo Manzanas, Daniel Alonso Fernández, Luis Antonio Rodríguez Toves, José María Martínez Sagarra.   

Abstract

OBJECTIVE: To emphasise a case of splenic hematoma secondary to ESWL.
METHODS: We report the case of a 69 year old patient with the diagnosis of left kidney stone who underwent ESWL. The treatment was performed with an electric lithotripter after pre-treatment antibiotic prophylaxis; 2000 shock waves of 18 Kv were given to the patient.
RESULTS: Patient presented abdominal pain and hematocrit descent after lithotripsy. The diagnosis of splenic hematoma was established after abdominal ultrasound and CT-scan and the patient was treated conservatively. He required a posterior emergency splenectomy secondary to infection of the hematoma, with the result of death secondary to septic shock.
CONCLUSION: Splenic lesion is an exceptional complication after ESWL. There are no studies about the effect of shock waves on the spleen, having been reported only four cases. It is believed that extreme care should be taken in cases with splenic pathology: leukaemia, lymphoma, etc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12455285

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  3 in total

1.  Lung contusion and cavitation with exudative plural effusion following extracorporeal shock wave lithotripsy in an adult: a case report.

Authors:  Nader Nouri-Majalan; Roghayyeh Masoumi; Abolhasan Halvani; Sara Moghaddasi
Journal:  J Med Case Rep       Date:  2010-08-31

2.  Spleen injury following left extracorporeal shockwave lithotripsy (ESWL).

Authors:  Serge P Marinkovic; Christina M Marinkovic; Donghua Xie
Journal:  BMC Urol       Date:  2015-02-18       Impact factor: 2.264

Review 3.  [Ureteral stricture after extracorporeal shock wave lithotripsy. Case report and overview of the spectrum of rare side effects of modern ESWL treatment].

Authors:  F Finter; L Rinnab; J Simon; B Volkmer; R Hautmann; R Kuefer
Journal:  Urologe A       Date:  2007-07       Impact factor: 0.803

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.